# Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia

> **NCT06425757** · PHASE4 · COMPLETED · sponsor: **Xie Kangjie** · enrollment: 36 (actual)

## Conditions studied

- Hypoproteinemia
- Pharmacokinetics
- Ciprofol

## Interventions

- **DRUG:** ciprofol

## Key facts

- **NCT ID:** NCT06425757
- **Lead sponsor:** Xie Kangjie
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-04
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-08-30
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06425757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06425757, "Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT06425757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*